HNRNPK and nasopharyngeal carcinoma: To evaluate the effect of hnRNPK knockdown on the sensitivity of NPC cells to cisplatin treatment in vivo, BALB/c nude mice bearing siRNA-Control or siRNA-hnRNPK 5–8 F cells were used as tumor models.